Filing Details

Accession Number:
0001437749-11-009753
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-12-22 16:49:47
Reporting Period:
2011-12-21
Filing Date:
2011-12-22
Accepted Time:
2011-12-22 16:49:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
352747 Unigene Laboratories Inc UGNE Medicinal Chemicals & Botanical Products (2833) 222328609
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1502054 Roxanne Tavakkol C/O Unigene Laboratories, Inc
81 Fulton Street
Boonton NJ 07005
Vp, Global Regulatory Affairs No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-12-21 1,500 $0.64 1,500 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct